Impact of demographic factors, medication and symptoms on disease-specific quality of life in inflammatory bowel disease
✍ Scribed by Johanna Haapamäki; Ulla Turunen; Risto P. Roine; Martti A. Färkkilä; Perttu E. T. Arkkila
- Publisher
- Springer Netherlands
- Year
- 2009
- Tongue
- English
- Weight
- 178 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0962-9343
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Approximately 20%-25% of all inflammatory bowel disease (ibd) cases have an onset in childhood or adolescence. beyond disease severity, little is known regarding determinants of health-related quality of life (hrqol) in this population. this study aimed to identify behavioral correla
Inflammatory bowel disease (IBD), which encompasses Crohn's disease (CD) and ulcerative colitis (UC), are chronic and debilitating conditions with unpredictable courses and complicated treatment. Pediatric IBD carries implications that extend beyond the health of the gastrointestinal tract. When the
## Background: Inflammatory bowel diseases (ibd) such as ulcerative colitis (uc) and crohn's disease (cd) have great impact on patients' health-related quality of life (hrqol). the aim of this study was to develop an integrated medical and psychological/ psychosocial group-based intervention progra
## Background: Crohn's disease and ulcerative colitis, referred to as inflammatory bowel diseases, affect mainly young adults and have an elevated morbidity and a negative effect on quality of life. this study aimed to compare the health-related quality of life between 2 randomized groups of patien